Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Dr. Aleksandr Kakinen is an NHMRC Emerging Leadership Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), University of Queensland. He completed his PhD in 2014 at Tallinn University of Technology, Estonia, and held a postdoctoral fellowship at Monash Institute of Pharmaceutical Sciences from 2016 to 2020.
Dr. Kakinen’s research focuses on neurodegenerative diseases, particularly amyloid-related disorders such as Parkinson’s and Alzheimer’s disease. His expertise spans structural biology, protein aggregation, neuroinflammation, and nanomedicine, with a special emphasis on developing brain-targeted delivery systems for neuroprotective therapies.
He has authored over 65 peer-reviewed publications in leading journals including Nature Communications, Advanced Science, ACS Nano, and Chemical Society Reviews. Dr. Kakinen also leads a research team that combines fundamental biophysics with translational studies to advance treatments for neurodegenerative disorders.
In addition to his scientific work, he founded a design studio specialising in scientific illustrations and biomedical animations, enhancing science communication through creative visual storytelling.
